SOURCE: BBK Worldwide

BBK Patient Recruitment and Engagement

June 16, 2015 09:00 ET

BBK Worldwide Appoints New Managing Director of Japan, Toshio Mori, Opens Tokyo Office

WASHINGTON, DC and BOSTON, MA--(Marketwired - June 16, 2015) - DIA 2015 Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, has appointed Toshio Mori to Managing Director of Operations, Japan. Mori will lead business development and help drive sales and marketing in Japan, and will report to BBK Principal, Global Resources Steven Fleishman. Mori is also responsible for establishing and growing the company's new Japan office, based in Tokyo.

Mori brings more than 25 years of pharmaceutical and medical device experience to the role. Before BBK, Mori established and then led operations at Japan-based Candela KK, a subsidiary of Syneron-Candela, a global market leader in the aesthetic medical device marketplace. Earlier in his career, he held senior sales and marketing positions at Sansui Electronic Co.

"Toshio's expertise across a broad set of disease areas -- from cancer to neurological disorders -- combined with his established leadership among physicians and study investigators will help us further extend our global reach and support the increased demand for clinical research in Japan," said Fleishman. "We remain committed to expanding our support in Japan, and are happy to be entering this new phase of growth with Toshio's support."

"I was drawn to BBK for its leadership in patent recruitment and engagement, as well as its commitment to patient centricity and diversity," said Mori. "I'm pleased to be joining the distinguished team and look forward to advancing the company's work in Japan."

With deep experience across many multinational patient recruitment and retention campaigns, BBK has worked with eight of the top 10 pharmaceutical companies in Japan, since opening its original Japan office in Osaka. The company's recruitment and engagement software solutions, consulting services and integrated cloud-based infrastructure supports proactive contingency action planning through access to real-time recruitment data tracking and management, and offers critical interfaces for referral management and enrollment reporting for Japan audiences.

Visit BBK booth #2026 at the DIA Annual Meeting to learn more about the company's software solutions and consulting services for improved patient recruitment and engagement. Members of the media and analyst communities interested in meeting with BBK Worldwide at the show can contact Juli Greenwood at 617-515-8412 or jgreenwood@bbkworldwide.com.

Follow @BBKWorldwide on Twitter and join the conversation with #DIA2015 and #BBKatDIA.

Additional Resources

About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment and engagement for the clinical trial industry. BBK's innovative software solutions and consulting services leverage the company's adaptive recruitment methodology to protect global enrollment integrity, specifically within an ever-changing or threatened landscape. For more information, visit www.bbkworldwide.com.

Contact Information